Vofatamab | m-entrepreneurship.com

Product Name :
Vofatamab

Search keywords :
Vofatamab

drugId :
null

Target Vo:
Fibroblast growth factor receptor 3

Target Vo Short Name :
FGFR3

Moa_Name:
Fibroblast growth factor receptor 3 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bioclin Therapeutics Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Urinary Bladder Neoplasms

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-eIF4E (Ser209) Antibody
Caspase 1 Antibody
CCR7 Antibody: CCR7 Antibody is an unconjugated, approximately 42 kDa, rabbit-derived, anti-CCR7 polyclonal antibody. CCR7 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog background without labeling.

Author: Betaine hydrochloride

Related Posts